We are monitoring the impact of COVID-19 on MEA Nuclear Imaging Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1548
Share on
Share on

Middle East & Africa Nuclear Imaging Market Research Report – Segmented By Diagnostic Technologies, Application, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1548
Pages: 138

MEA Nuclear Imaging Market Size (2021 to 2026)

The Nuclear Imaging Market size in the Middle East & Africa was worth USD 0.91 billion in 2021 and is estimated to be growing at a CAGR of 7.83%, to reach USD 1.32 billion by 2026.

One of the key factors driving the market expansion is the rising frequency of cancer and heart disorders in the MEA region. Nuclear medicine holds a lot of promise in terms of cancer and heart disease treatment. The cancer burden is rising due to variables such as population aging, poor food, smoking, and physical inactivity. According to the World Health Organization, cancer incidence in the Middle East is rising, with many cases anticipated to quadruple by 2030. Minimally invasive procedures have aided the trend toward precise surgical treatment. Medical imaging-guided therapy is a new field that has applications in minimally invasive surgery, interventional radiology, and computer-aided visualization. The demand for imaging guidance has expanded due to these novel surgical procedures, as have the most advanced imaging methods. The shift from standalone to hybrid modalities, advances in radiotracers, the growing focus on personalized medicine, investments in diagnostic imaging centers through public-private partnerships, and the rising incidence and prevalence of cancer and cardiac ailments are all driving this market forward. The PET and SPECT market is being driven by rising knowledge of the benefits of nuclear imaging among physicians and clinical researchers and expanding application areas such as oncology and neurological diseases.

Nuclear medicine imaging is critical in diagnosing and managing patients with coronary artery disease (CAD), atherosclerosis, and other cardiovascular disorders in cardiology. Nuclear medicine is a key growth element for market analysis since it plays an important part in diagnosing and managing patients with various disorders. Image processing and reconstruction, computer-assisted medical condition recognition, 3D image production, and the employment of appropriate quality control systems are all possible with data integrated imaging systems. Physicians may compare scans with the use of data integration to monitor illness progression properly.

The primary restrictions for the MEA nuclear imaging market include rising research and development costs and highly advanced hybrid nuclear imaging equipment. Furthermore, the market's growth is further estimated to be hampered by the short half-life of radiopharmaceuticals, supply instability, logistical challenges, and rigorous regulatory rules, as well as competition from traditional alternative diagnostic techniques. In addition, increased costs of nuclear imaging equipment and a shortage of Tc-99m are among the primary reasons hindering market expansion and posing further challenges to the nuclear imaging devices market in the forecast period.

This research report on the Middle East and Africa Nuclear Imaging Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Standalone PET Nuclear Imaging
  • Standalone SPECT Nuclear Imaging
  • Hybrid Nuclear Imaging

By Application: 

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End-User: 

  • Hospitals
  • Diagnostic Centers
  • Research Centers

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In terms of market share, South Africa leads the market in this region. Other significant markets in this region include UAE, Israel, and Nigeria. The massive rise in spending in the healthcare division in this region has increased Nuclear Imaging devices' demand, thereby providing lucrative growth prospects for the Nuclear Imaging device manufacturers. Due to technical improvements in the healthcare business and rising healthcare expenditure, the UAE dominates the Middle East and Africa market. The rapid rise in this region can be due to increasing chronic disease incidence, increased awareness of the benefits of early disease detection, and improved healthcare systems in the region. In the forecasted period, rising technical improvements, increased demand for qualified professionals, increased demand for data integrated imaging systems, and increased demand in the region will provide new opportunities for the nuclear imaging equipment market.

KEY MARKET PLAYERS:

Companies playing a vital role in the Middle East & Africa Nuclear Imaging market in this report are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Technologies                        

                                5.1.1 Introduction           

                                5.1.2 PET Radioisotopes

                                                5.1.2.1 Rubidium-82

                                                5.1.2.2 Fluorine-18

                                                5.1.2.3 Others

                                5.1.3 SPECT Radioisotopes          

                                                5.1.3.1 Thallium-201

                                                5.1.3.2 Technetium-99m

                                                5.1.3.3 Xenon-133

                                                5.1.3.4 Iodine-123

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies                

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies              

                                5.1.6 Market Share Analysis, By Diagnostic Technologies               

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PET             

                                                5.2.2.1 Cardiology

                                                5.2.2.2 Oncology

                                                5.2.2.3 Neurology

                                                5.2.2.4 Others

                                5.2.3 SPECT        

                                                5.2.3.1 Lymphoma

                                                5.2.3.2 Neurology

                                                5.2.3.3 Cardiology

                                                5.2.3.4 Thyroid

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application        

                                5.2.6 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technologies

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technologies

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technologies

                                                6.1.5.3 By Application

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Mallinckrodt plc                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens Medical Solutions                  

                8.3 Hitachi Medical Corporation               

                8.4 Medtronic Inc.                          

                8.5 General Electric Co. (healthcare division)                       

                8.6 IBA Group                   

                8.7 Positron Corporation                              

                8.8 Philips Medical Systems                        

                8.9 Naviscan                      

                8.10 Toshiba Medical Systems Corporation                          

                8.11 Carestream Health                

                8.12 Lantheus Medical Imaging Inc.                         

                8.13 Cardinal Health Inc.                              

                8.14 Bayer AG                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  3. Middle East & Africa PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East & Africa Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East & Africa Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East & Africa Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  15. Middle East & Africa Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  16. Middle East & Africa PET Market, By Region, From 2021 to 2026 (USD Billion)
  17. Middle East & Africa Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  18. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  19. Middle East & Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. Middle East & Africa Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  21. Middle East & Africa Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  22. Middle East & Africa SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  23. Middle East & Africa Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  24. Middle East & Africa Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  25. Middle East & Africa Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  26. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  27. Middle East & Africa Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  28. Middle East & Africa Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  29. Middle East Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  30. Middle East Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  31. Middle East Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  32. Middle East Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  33. Middle East Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  34. Middle East Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  35. Africa Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  36. Africa Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  37. Africa Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  38. Africa Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  39. Africa Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  40. Africa Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample